Selvita is a drug discovery CRO. The company was established in 2007 and currently employs over 450 scientists, among which 30% are PhDs. Selvita provides comprehensive solutions involving in silico drug design, synthesis of target-focused libraries, SAR and ADME-driven lead optimization and toxicity prediction, followed by complex preclinical in vitro development.